[Was it paradoxal embolism? Cerebellar infarction, patent foramen ovale and APC resistance--a controversial combination and and therapeutic challenge].
Valladares
Carlos
C
Kardiologiska kliniken, Hjärtcentrum. carlos.valladares@lio.se
Broqvist
Mats
M
Nylander
Eva
E
Callander
Margarita
M
D020016:Activated Protein C Resistance / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D006328:Cardiac Catheterization; D002526:Cerebellar Diseases / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D002544:Cerebral Infarction / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D003937:Diagnosis, Differential; D019320:Embolism, Paradoxical / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006344:Heart Septal Defects, Atrial / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008488:Medical Illustration; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D020521:Stroke / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D014463:Ultrasonography; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin